Arvee Laboratories (India) IPO listing price is ₹ 62.50, issue price is [●], and currently trading at ₹ 184.01 as on May 30, 2025. Arvee Laboratories (India) IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Arvee Laboratories (India) IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Chemical - Speciality sector. Sarthi Capital Advisors is the merchant banker of Arvee Laboratories (India) IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Arvee Laboratories (India) IPO offer price is ₹ 61.00 and got listed at ₹ 62.50. Read Arvee Laboratories (India) IPO details mentioned above.The IPO of Arvee Laboratories (India) Limited was listed on 22nd February 2018. As of today, Arvee Laboratories (India) IPO is trading at ₹ 184.01, compared to the previous day’s close of ₹ 174.63. Read the report above for detailed IPO performance.
The issue price of Arvee Laboratories (India) IPO was [●] per equity share.
Arvee Laboratories (India) IPO was listed at ₹62.50 on the stock exchange on 22nd February 2018. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Arvee Laboratories (India) IPO is ₹ 184.01.
The 52-week high for Arvee Laboratories (India) IPO is ₹ 235.79, while the 52-week low is ₹ 126.54. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Arvee Laboratories (India) IPO listed at ₹ 62.50 against the issue price of [●] per equity share, showing a listing day gain/loss of 1.5 (2.46%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Arvee Laboratories (India) IPO stock moved from its listing price of ₹ 62.50 to the current price of ₹184.01 per equity share, reflecting a change of 194.42% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Arvee Laboratories (India) IPO issue date of May 30, 2025 and CMP of ₹184.01, the estimated CAGR is approximately 16.39%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Arvee Laboratories (India) IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Arvee Laboratories (India) Financial Review Page
Merchant Banker(s) of Arvee Laboratories (India) IPO: Sarthi Capital Advisors Private Limited
Arvee Laboratories (India) IPO subscription was 2.90 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Arvee Laboratories (India) IPO listed at a listing price of 62.50 against the offer price of 61.00.
The current market price of Arvee Laboratories (India) is 184.01.
Why Us?